Alteration in the transcriptional profile of livers from brain-dead organ donors

Transplantation

Volumn 82, Issue 1, 2006, Pages 69-79

  Colombo, Gualtiero ^a   Gatti, Stefano ^a   Turcatti, Flavia ^a   Lonati, Caterina ^a   Sordi, Andrea ^a   Rossi, Giorgio ^a   Bonino, Ferruccio ^a   Catania, Anna ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Brain death; Liver; Microarray; Organ transplantation

Indexed keywords

AMINE; COMPLEMENTARY DNA; XENOBIOTIC AGENT;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD CLOTTING; BRAIN DEATH; CADAVER DONOR; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG DEGRADATION; ELECTRON TRANSPORT; ENERGY METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIVER; LIVER BIOPSY; LIVER RESECTION; LIVER TRANSPLANTATION; METABOLISM; MORPHOGENESIS; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; ADULT; AGED; LIVING DONOR; MALE; MIDDLE AGED;

ADULT; AGED; BRAIN DEATH; GENE EXPRESSION PROFILING; HUMANS; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 33747486694     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000225829.07208.58     Document Type: Article

References (63)

1. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
2. Zweers N, Petersen AH, van der Hoeven JA, et al. Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation 2004; 78: 1251.
3. Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005; 5: 684.
4. Segel LD, vonHaag DW, Zhang J, Follette DM. Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J Heart Lung Transplant 2002; 21: 804.
5. Pratschke J, Wilhelm MJ, Laskowski I, et al. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001; 12: 2474.
6. van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874.
7. Nyhof E, Wiehl S, Steinhoff J, et al. Relationship between donor factors, immunogenic up-regulation, and outcome after kidney transplantation. Transplant Proc 2005; 37: 1605.
8. Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc 2005; 37: 367.
9. Kuecuek O, Mantouvalou L, Klemz R, et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc 2005; 37: 387.
10. Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978.
11. Jassem W, Koo DD, Cerundolo L, et al. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003; 75: 2001.
12. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232: 263.
13. van der Hoeven JA, Lindell S, van Schilfgaarde R, et al. Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr. Transplantation 2001; 72: 1632.
14. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405.
15. van der Hoeven JA, Moshage H, Schuurs T, et al. Brain death induces apoptosis in donor liver of the rat. Transplantation 2003; 76: 1150.
16. Schuurs TA, Gerbens F, van der Hoeven JA, et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004; 4: 1972.
17. Jassem W, Koo DD, Muiesan P, et al. Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation. Transplantation 2003; 75: 1386.
18. Kendziorski C, Irizarry RA, Chen KS, et al. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A 2005; 102: 4252.
19. Dennis G, Jr., Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: P3.
20. Hosack DA, Dennis G, Jr., Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
21. Pavlov VA, Wang H, Czura CJ, et al. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003; 9: 125.
22. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5: 575.
23. Dodds AW. Which came first, the lectin/classical pathway or the alternative pathway of complement? Immunobiology 2002; 205: 340.
24. Tschopp J, Chonn A, Hertig S, French LE. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol 1993; 151: 2159.
25. Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101: 20.
26. Nebert DW, McKinnon RA. Cytochrome P450: evolution and functional diversity. Prog Liver Dis 1994; 12: 63.
27. Li AP, Kaminski DL, Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995; 104: 1.
28. Wheatcroft SB, Kearney MT, Shah AM, et al. Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1. Diabetes 2003; 52: 2075.
29. Ferry RJ, Jr., Katz LE, Grimberg A, et al. Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res 1999; 31: 192.
30. Weber MM, Auernhammer CJ, Lee PD, et al. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Horm Res 2002; 57: 105.
31. Kamasani U, Liu AX, Prendergast GC. Genetic response to farnesyltransferase inhibitors: proapoptotic targets of RhoB. Cancer Biol Ther 2003; 2: 273.
32. Inuzuka H, Nanbu-Wakao R, Masuho Y, et al. Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. Biochem Biophys Res Commun 1999; 265: 664.
33. Mueller L, Broering DC, Meyer J, et al. The induction of the immediate-early-genes Egr-1, PAI-1 and PRL-1 during liver regeneration in surgical models is related to increased portal flow. J Hepatol 2002; 37: 606.
34. Fahmy RG, Dass CR, Sun LQ, et al. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026.
35. Odom DT, Zizlsperger N, Gordon DB, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378.
36. Hayhurst GP, Lee YH, Lambert G, et al. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21: 1393.
37. Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003; 34: 292.
38. Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002; 23: 443.
39. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001; 413: 131.
40. Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta 2000; 1482: 157.
41. Hamann L, Alexander C, Stamme C, et al. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect Immun 2005; 73: 193.
42. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74.
43. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469.
44. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003; 24: 155.
45. Regner A, Kaufman M, Friedman G, Chemale I. Increased serum S100beta protein concentrations following severe head injury in humans: a biochemical marker of brain death? Neuroreport 2001; 12: 691.
46. Moench C, Uhrig A, Lohse AW, Otto G. The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation. Transplant Proc 2003; 35: 1452.
47. Chen HW, Kuo HT, Lu TS, et al. Cytochrome c oxidase as the target of the heat shock protective effect in septic liver. Int J Exp Pathol 2004; 85: 249.
48. Kishi T, Takahashi T, Usui A, et al. Cytosolic NADPH-UQ reductase, the enzyme responsible for cellular ubiquinone redox cycle as an endogenous antioxidant in the rat liver. Biofactors 1999; 9: 189.
49. Banning A, Deubel S, Kluth D, et al. The GI-GPx gene is a target for Nrf2. Mol Cell Biol 2005; 25: 4914.
50. Shackel NA, McGuinness PH, Abbott CA, et al. Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology 2003; 38: 577.
51. Delgado Hernandez R, Demitri MT, Carlin A, et al. Inhibition of systemic inflammation by central action of the neuropeptide α-melanocyte- stimulating hormone. Neuroimmunomodulation 1999; 6: 187.
52. Lipton JM, Macaluso A, Hiltz ME, Catania A. Central administration of the peptide α-MSH inhibits inflammation in the skin. Peptides 1991; 12: 795.
53. Yoneda M, Goto M, Nakamura K, et al. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. Regul Pept 2005; 125: 119.
54. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853.
55. Dulaney R, Woerner J, Macaluso A, et al. Changes in peripheral inflammation induced by CNS actions of an α-MSH analog and of endogenous pyrogen. Prog Neuroendocrinimmunol 1992; 5: 179.
56. De Simoni MG, Sironi M, De Luigi A, et al. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med 1990; 171: 1773.
57. Sundar SK, Becker KJ, Cierpial MA, et al. Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci U S A 1989; 86: 6398.
58. Yoneda M, Watanobe H, Terano A. Central regulation of hepatic function by neuropeptides. J Gastroenterol 2001; 36: 361.
59. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003; 53: 123.
60. Morganti-Kossmann MC, Rancan M, Otto VI, et al. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001; 16: 165.
61. Magnoni S, Stocchetti N, Colombo G, et al. a-Melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma 2003; 20: 251.
62. Raghavendra Rao VL, Dhodda VK, Song G, et al. Traumatic brain injury-induced acute gene expression changes in rat cerebral cortex identified by GeneChip analysis. J Neurosci Res 2003; 71: 208.
63. Esche C, Stellato C, Beck LA. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 2005; 125: 615.